Showing results (171-180 of 220) with videos related to
Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|April 2, 2003
Warfarin and aspirin give more benefit than aspirin alone but also more bleeding after myocardial infarctionSheila A DoggrellThe Journal of Pharmacy and Pharmacology|October 25, 2002
Functional beta1- and beta2-adrenoceptors in the left and right atrium of pre-hypertensive ratsSheila A DoggrellExpert Opinion on Pharmacotherapy|March 5, 2003
ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction?Sheila A DoggrellExpert Opinion on Pharmacotherapy|November 20, 2002
Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?Sheila A DoggrellExpert Opinion on Investigational Drugs|February 15, 2012
Dalcetrapib--restoring belief in modulating CETP as a beneficial mechanism in cardiovascular diseaseSheila A DoggrellCurrent Opinion in Investigational Drugs (London, England : 2000)|September 29, 2005
Taking the 20-HETE out of the cardiovascular system: the potential of 20-HETE synthesis inhibitorsSheila A DoggrellCurrent Opinion in Investigational Drugs (London, England : 2000)|September 29, 2005
BG-9928 (Biogen Idec)Sheila A DoggrellExpert Opinion on Pharmacotherapy|October 6, 2004
Is vasopressin-receptor antagonism an advancement in the treatment of heart failure?Sheila A DoggrellExpert Opinion on Pharmacotherapy|August 28, 2004
Atorvastatin versus pravastatin: intensive versus moderate lipid loweringSheila A DoggrellExpert Opinion on Investigational Drugs|September 8, 2005
Rho-kinase inhibitors show promise in pulmonary hypertensionSheila A DoggrellPageof 22